References
- Elliott H. Attention deficit hyperactivity disorder in adults: a guide for the primary care physician. Southern Medical Journal 2002; 95(7): 736–42.
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders, (4th ed, text revision). Washington, D: American Psychiatric Association, 2000.
- Das D, Cherbuin N, Easteal S, Anstey KJ. Attention Deficit/Hyperactivity Disorder Symptoms and Cognitive Abilities in the Late-Life Cohort of the PATH through Life Study. PLoS ONE 2014; 9(1): e86552. (doi:10.1371/journal.pone.0086552). [CrossRef]
- Oztop D, Altun H, Baskol G, Ozsoy S. Oxidative stress in children with attention deficit hyperactivity disorder. Clinical Biochemistry 2012; 45(10–11): 745–8. [CrossRef]
- Tripp G, Wickens JR. Neurobiology of ADHD. Neuropharmacology 2009; 57(7–8): 579–89. [CrossRef]
- Sies H. Oxidative stress: Oxidants and antioxidants. Experimental Physiology 1997; 82(2): 291–5.
- Siwek M, Kuaema MS, Dudek D, Styczeñ K, Szewczyk B, Kotarska K, et al. Oxidative stress markers in affective disorders. Pharmacological Reports 2013; 65(6): 1558–71. [CrossRef]
- Bulut M, Selek S, Bez Y, Kaya MC, Gunes M, Karababa F, et al. Lipid peroxidation markers in adult attention deficit hyperactivity disorder: New findings for oxidative stress. Psychiatry Research 2013; 209(3): 638–42. [CrossRef]
- Savas HA, Herken H, Yurekli M, Uz E, Tutkun H, Zoroglu SS, et al. Possible pathopsychological role of nitric oxide and adrenomedullin in bipolar disorder. Neuropsychobiology 2002; 45(2): 57–61. [CrossRef]
- Kuloglu M, Atmaca M, Tezcan E, Gecici O, Tunckol H, Ustundag B. Antioxidant enzyme activities and malondialdehyde levels in patients with obsessive-compulsive disorder. Neuropsychobiology 2002; 46(4): 27–32. [CrossRef]
- Andreazza AC, Frey BN, Erdtmann B, Salvador M, Rombaldi F, Santin A, et al. DNA damage in bipolar disorder. Psychiatry Res 2007; 153(1): 27–32. [CrossRef]
- Copoglu US, Virit O, Bulbul F, Unal A, Alpak G, Savas HA. An investigation on oxidative metabolism and oxidative DNA damage among schizophrenia patients with or without symptomatic remission. Klinik Psikofarmakoloji Bulteni-Bulletin of Clinical Psychopharmacology 2012; 22(Suppl. 1): S129.
- Selek S, Bulut M, Ocak AR, Kalenderoglu A, Savas HA. Evaluation of total oxidative status in adult attention deficit hyperactivity disorder and its diagnostic implications. Psychiatry Res 2012; 46(4): 451–5. [CrossRef]
- Selek S, Savas HA, Gergerlioglu HS, Bulut M, Yilmaz HR. Oxidative imbalance in adult attention deficit/hyperactivity disorder. Biological Psychology 2008c; 79(2): 256–9. [CrossRef]
- Akyol O, Zoroglu SS, Armutcu F, Sahin S, Gurel A. Nitric oxide as a physiopathological factor in neuropsychiatric disorders. In Vivo 2004; 18(3): 377–90.
- Unal D, Ulug B. Neurobiology of Attention Deficit/ Hyperactivity Disorder. Turkiye Klinikleri J Psychiatry Special Topics 2012; 5(1): 20–8. (Turkish)
- Zhang XY, Yao JK. Oxidative stress and therapeutic implications in psychiatric disorders. Prog Neuro- Psychopharmacol Biol Psychiatry 2013; 46: 197–9. [CrossRef]
- Atmaca G. Antioxidant Effects of Sulfur Containing Amino acids. Yonsei Medical Journal 2004; 45(5): 776–88.
- Vekaria H, Sadagopan K, Adamec J, Jarori GK, Prabha CR. Thiol stress induces catalaseA in Streptomyces coelicolor. In: Méndez-Vilas A (editor). Communicating Current Research and Educational Topics and Trends in Applied Microbiology. Formatex; 2007. p. 246–54.
- Gunay S, Savran C, Aksoy UM, Maner F, Turgay A, Yargic I. The norm study, transliteral equivalence, validity, reliability of adult hyperactivity scale in Turkish adult population. Turkiye'de Psikiyatri 2006; 8(2): 98–107. (Turkish)
- Hu ML, Louie S, Cross CE, Motchnik P, Halliwell B. Antioxidant protection against hypochlorous acid in human plasma. J Lab Clin Med 1993; 121(2): 257–61.
- Goth L. A simple method for determination of serum catalase activity and revision of reference range. Clin Chim Acta 1991; 196(2–3): 143–52. [CrossRef]
- Ceylan M, Sener S, Bayraktar AC, Kavutcu M. Oxidative imbalance in child and adolescent patients with attention- deficit/hyperactivity disorder. Prog Neuro-Psychopharmacol Biol Psychiatry 2010; 34(8): 1491–4. [CrossRef]
- Savas HA, Gergerlioglu HS, Armutcu F, Herken H, Yilmaz HR, Kocoglu E. Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: impact of past episodes. World Journal of Biological Psychiatry 2006; 7(1): 51–5. [CrossRef]
- Flatow J, Buckley P, Miller BJ. Meta-Analysis of Oxidative Stress in Schizophrenia. Biol Psychiatry 2013; 74(6): 400–9. [CrossRef]